Skip to main content

ELAN Elanco Animal Health Incorporated

Healthcare

24.10 +1.04 +4.51% Close 11/2
Since 2024-12-02 +71.1%
Open
23.55
High
24.22
Low
23.31
Prev close
23.06
Volume
6.5M
Amplitude
3.95%
P/B
1.8
Revenue YoY (TTM)
+11.9%
52W 19.40 27.98

Is Elanco Animal Health Incorporated a buy? Fundamentals and valuation first

As of 2026-10-30

Valuation: Fair, Momentum: Good, Risk / liquidity: Good; Growth: Weak.

Valuation Fair Free-cash-flow yield is Good, but Price / book is Pricey.
TTM P/E -57.65 N/A
Price / book 1.75 55th percentile Pricey
Free-cash-flow yield (%) 3.29 59th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Neutral FCF margin, TTM is Good, but ROE, TTM is Average.
ROE, TTM (%) -3.02 36th percentile Average
Operating margin, TTM (%) 9.2 54th percentile Good
FCF margin, TTM (%) 7.55 56th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Weak Revenue growth, TTM YoY is Good, but Diluted EPS growth, TTM YoY is Lagging.
Revenue growth, TTM YoY (%) 11.95 64th percentile Good
Diluted EPS growth, TTM YoY (%) -146.19 14th percentile Lagging
Momentum Good All 2 indicators are Good.
60-day return (%) -4.71 55th percentile Good
240-day return (%) 9.34 62th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Good 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 106,103,296 88th percentile Top
60-day annualized volatility (%) 34.21 39th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Elanco Animal Health Incorporated (ELAN) today

1 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Elanco Animal Health Incorporated to every stock like it

AI finds several complementary traits of Elanco Animal Health Incorporated across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Elanco Animal Health Incorporated

Elanco Animal Health Incorporated (ELAN) peers and tracking

Watchlist

This page refreshes daily after the close. Add Elanco Animal Health Incorporated to your watchlist to track signal changes on your next visit.

Elanco Animal Health Incorporated (ELAN) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Filed revenue acceleration

Active · now 11.95%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

5 historical occurrences (since 2021-05-07)

Average forward return after Filed revenue acceleration

20-day: Win 40%, Sample 5, Median -5.61%, Excess -2.43%, Beat mkt rate 40%

60-day: Win 40%, Sample 5, Median -1.76%, Excess -5.99%, Beat mkt rate 40%

60 days after: historical avg -4.02%

20-day -2.06%
60-day -4.02%
20-day
60-day
Win
40%
40%
Sample
5
5
Median
-5.61%
-1.76%
Excess
-2.43%
-5.99%
Beat mkt rate
40%
40%

Over 5 occurrences, 60-day forward avg declined 4.02%, lagged the market by 5.99 pts; win rate 40%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

11 times historically; 60-day forward avg -3.48%, win rate 27.3%, beating the market by -7.94 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest

9 times historically; 60-day forward avg +13.95%, win rate 55.6%, beating the market by +5.9 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

27 times historically; 60-day forward avg +0.22%, win rate 44.4%, beating the market by -3.52 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.